Reaction Details |
![](/images/Email.png) | Report a problem with these data |
Target | Oxysterols receptor LXR-beta |
---|
Ligand | BDBM95939 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | Counterscreen for agonists of the daf-12 abnormal Dauer Formation: Luminescence-based cell-based dose response screening assay to identify agonists of the Liver-X-Receptor (LXR) |
---|
EC50 | 67522±n/a nM |
---|
Citation | PubChem, PC Counterscreen for agonists of the daf-12 abnormal Dauer Formation: Luminescence-based cell-based dose response screening assay to identify agonists of the Liver-X-Receptor (LXR) PubChem Bioassay(2013)[AID] |
---|
More Info.: | Get all data from this article, Solution Info, Assay Method |
---|
|
Oxysterols receptor LXR-beta |
---|
Name: | Oxysterols receptor LXR-beta |
Synonyms: | LXRB | Liver X receptor beta (NR1H2) | Liver X, LXR beta | NER | NR1H2 | NR1H2_HUMAN | Nuclear receptor NER | UNR | Ubiquitously-expressed nuclear receptor |
Type: | Enzyme Catalytic Domain |
Mol. Mass.: | 50978.79 |
Organism: | Homo sapiens (Human) |
Description: | P55055 |
Residue: | 460 |
Sequence: | MSSPTTSSLDTPLPGNGPPQPGAPSSSPTVKEEGPEPWPGGPDPDVPGTDEASSACSTDW
VIPDPEEEPERKRKKGPAPKMLGHELCRVCGDKASGFHYNVLSCEGCKGFFRRSVVRGGA
RRYACRGGGTCQMDAFMRRKCQQCRLRKCKEAGMREQCVLSEEQIRKKKIRKQQQESQSQ
SQSPVGPQGSSSSASGPGASPGGSEAGSQGSGEGEGVQLTAAQELMIQQLVAAQLQCNKR
SFSDQPKVTPWPLGADPQSRDARQQRFAHFTELAIISVQEIVDFAKQVPGFLQLGREDQI
ALLKASTIEIMLLETARRYNHETECITFLKDFTYSKDDFHRAGLQVEFINPIFEFSRAMR
RLGLDDAEYALLIAINIFSADRPNVQEPGRVEALQQPYVEALLSYTRIKRPQDQLRFPRM
LMKLVSLRTLSSVHSEQVFALRLQDKKLPPLLSEIWDVHE
|
|
|
BDBM95939 |
---|
n/a |
---|
Name | BDBM95939 |
Synonyms: | 4-[4-(5-Thiophen-2-yl-[1,3,4]oxadiazol-2-yl)-phenyl]-morpholine | 4-[4-(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)phenyl]morpholine | 4-[4-[5-(2-thienyl)-1,3,4-oxadiazol-2-yl]phenyl]morpholine | MLS000026817 | SMR000002070 | cid_650568 |
Type | Small organic molecule |
Emp. Form. | C16H15N3O2S |
Mol. Mass. | 313.374 |
SMILES | C1CN(CCO1)c1ccc(cc1)-c1nnc(o1)-c1cccs1 |
Structure |
|